Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?

Arnold, 2015, Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European cancer observatory, Eur J Cancer, 51, 1164, 10.1016/j.ejca.2013.09.002

Cremers, 2010, Prostate cancer: Trends in incidence, survival and mortality in The Netherlands, 1989-2006, Eur J Cancer, 46, 2077, 10.1016/j.ejca.2010.03.040

Schroder, 2009, Screening and prostate-cancer mortality in a randomized European study, N Engl J Med, 360, 1320, 10.1056/NEJMoa0810084

European Association of Urology. European Association of Urology Guidelines on Prostate Cancer. 2013. http://www.uroweb.org/gls/pdf/09_Prostate_Cancer_LR.pdf.

Heijmink, 2006, A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer, Eur Radiol, 16, 927, 10.1007/s00330-005-0035-y

Djavan, 2000, Optimal predictors of prostate cancer on repeat prostate biopsy: A prospective study of 1,051 men, J Urol, 163, 1144, 10.1016/S0022-5347(05)67711-7

Welch, 2007, Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era, J Natl Cancer Inst, 99, 1395, 10.1093/jnci/djm119

Epstein, 2012, Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: Incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades, Eur Urol, 61, 1019, 10.1016/j.eururo.2012.01.050

Wu, 2012, Usefulness of diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer, Acad Radiol, 19, 1215, 10.1016/j.acra.2012.05.016

Somford, 2008, Diffusion and perfusion MR imaging of the prostate, Magn Reson Imaging Clin N Am, 16, 685, 10.1016/j.mric.2008.07.002

Pinto, 2011, Imaging in prostate cancer diagnosis: Present role and future perspectives, Urol Int, 86, 373, 10.1159/000324515

Pinto, 2012, Imaging in prostate cancer staging: Present role and future perspectives, Urol Int, 88, 125, 10.1159/000335205

Barentsz, 2012, ESUR prostate MR guidelines 2012, Eur Radiol, 22, 746, 10.1007/s00330-011-2377-y

Barentsz, 2016, Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use, Eur Urol, 69, 41, 10.1016/j.eururo.2015.08.038

European Society of Urogenital Radiology. PI-RADS v2 prostate imaging and report and data system: Version 2. http://www.esur.org/esur-guidelines/prostate-mri.

Epstein, 1994, Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer, JAMA, 271, 368, 10.1001/jama.1994.03510290050036

Bastian, 2004, Characteristics of insignificant clinical T1c prostate tumours. A contemporary analysis, Cancer, 101, 2001, 10.1002/cncr.20586

D’Amico, 1997, Outcome based staging for clinically localized adenocarcinoma of the prostate, J Urol, 158, 1422, 10.1016/S0022-5347(01)64230-7

D’Amico, 1998, Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localised prostate cancer, JAMA, 280, 969, 10.1001/jama.280.11.969

Thompson, 2014, Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: A prospective study, J Urol, 192, 67, 10.1016/j.juro.2014.01.014

Ahmed, 2011, Characterising clinically significant prostate cancer using template prostate mapping biopsy, J Urol, 186, 458, 10.1016/j.juro.2011.03.147

Kasivisvanathan, 2013, Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer, J Urol, 189, 860, 10.1016/j.juro.2012.10.009

Pokorny, 2014, Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies, Eur Urol, 66, 22, 10.1016/j.eururo.2014.03.002

Pinto, 2011, Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging, J Urol, 186, 1281, 10.1016/j.juro.2011.05.078

Moore, 2013, Image-guided prostate biopsy using magnetic resonance imaging-derived targets: A systematic review, Eur Urol, 63, 125, 10.1016/j.eururo.2012.06.004

Overduin, 2013, MRI-guided biopsy for prostate cancer detection: A systematic review of current clinical results, Curr Urol Rep, 14, 209, 10.1007/s11934-013-0323-z

Roethke, 2014, Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla, Eur Radiol, 24, 344, 10.1007/s00330-013-3017-5

Hoeks, 2012, Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: Detection of clinically significant prostate cancers, Eur Urol, 62, 902, 10.1016/j.eururo.2012.01.047

Hadaschik, 2011, A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion, J Urol, 186, 2214, 10.1016/j.juro.2011.07.102

Rastinehad, 2014, Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy, J Urol, 191, 1749, 10.1016/j.juro.2013.12.007

Kuru, 2013, Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer, J Urol, 190, 1380, 10.1016/j.juro.2013.04.043

Valerio, 2015, Detection of clinically significant prostate cancer using magnetic resonance imaging-ultrasound fusion targeted biopsy: A systematic review, Eur Urol, 68, 8, 10.1016/j.eururo.2014.10.026

Labanaris, 2010, Prostate cancer detection using an extended prostate biopsy schema in combination with additional targeted cores from suspicious images in conventional and functional endorectal magnetic resonance imaging of the prostate, Prostate Cancer Prostatic Dis, 13, 65, 10.1038/pcan.2009.41

Puech, 2013, Prostate cancer diagnosis: Multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy—prospective multicentre study, Radiology, 268, 461, 10.1148/radiol.13121501

Booth, 2006, Brimful of STARLITE”: Toward standards for reporting literature searches, J Med Libr Assoc, 94, 421

Moher, 2010, Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement, Int J Surg, 8, 336, 10.1016/j.ijsu.2010.02.007

Whiting, 2011, QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies, Ann Intern Med, 155, 529, 10.7326/0003-4819-155-8-201110180-00009

Moore, 2013, Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: Recommendations from an international working group, Eur Urol, 64, 544, 10.1016/j.eururo.2013.03.030

Altman, 2000

Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Version 5.1.0. The Cochrane Collaboration, 2011. http://handbook.cochrane.org.

Schoots, 2015, Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: A systematic review and meta-analysis, Eur Urol, 68, 438, 10.1016/j.eururo.2014.11.037

Wysock, 2014, A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: The PROFUS trial, Eur Urol, 66, 343, 10.1016/j.eururo.2013.10.048

Wegelin, 2015, The future trial: Fusion target biopsy of the prostate using real-time ultrasound and MR images. A multicentre RCT on target biopsy techniques in the diagnosis of prostate cancer, J Clin Trials, 5, 248, 10.4172/2167-0870.1000248

Vourganti, 2012, Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies, J Urol, 188, 2152, 10.1016/j.juro.2012.08.025

Shakir, 2014, Identification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsy, J Urol, 192, 1642, 10.1016/j.juro.2014.08.002

Peltier, 2015, MRI-targeted biopsies versus systematic transrectal ultrasound guided biopsies for the diagnosis of localized prostate cancer in biopsy naive men, Biomed Res Int, 2015, 571708, 10.1155/2015/571708

Quentin, 2014, Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naive men with elevated prostate specific antigen, J Urol, 192, 1374, 10.1016/j.juro.2014.05.090

Radtke, 2015, Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance, J Urol, 193, 87, 10.1016/j.juro.2014.07.098

Siddiqui, 2015, Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer, JAMA, 313, 390, 10.1001/jama.2014.17942

Hambrock, 2008, Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility, Invest Radiol, 43, 686, 10.1097/RLI.0b013e31817d0506

Hambrock, 2010, Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen, J Urol, 183, 520, 10.1016/j.juro.2009.10.022

Miyagawa, 2010, Real-time virtual sonography for navigation during targeted prostate biopsy using magnetic resonance imaging data, Int J Urol, 17, 855, 10.1111/j.1442-2042.2010.02612.x

Franiel, 2011, Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding–multiparametric MR imaging for detection and biopsy planning, Radiology, 259, 162, 10.1148/radiol.10101251

Park, 2011, Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy, AJR Am J Roentgenol, 197, W876, 10.2214/AJR.11.6829

Portalez, 2012, Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients, Eur Urol, 62, 986, 10.1016/j.eururo.2012.06.044

Rouse, 2011, Multi-parametric magnetic resonance imaging to rule-in and rule-out clinically important prostate cancer in men at risk: a cohort study, Urol Int, 87, 49, 10.1159/000325880

Arsov, 2012, Repeat transrectal ultrasound biopsies with additional targeted cores according to results of functional prostate MRI detects high-risk prostate cancer in patients with previous negative biopsy and increased PSA – a pilot study, Anticancer Res, 32, 1087

Nagel, 2013, Differentiation of prostatitis and prostate cancer by using diffusion-weighted MR imaging and MR-guided biopsy at 3 T, Radiology, 267, 164, 10.1148/radiol.12111683

Quentin, 2013, 3-T in-bore MR-guided prostate biopsy based on a scoring system for target lesions characterization, Acta Radiol, 54, 1224, 10.1177/0284185113492972

Junker, 2013, Evaluation of the PI-RADS scoring system for classifying mpMRI findings in men with suspicion of prostate cancer, Biomed Res Int, 2013, 252939, 10.1155/2013/252939

Rosenkrantz, 2013, 3.0 T multiparametric prostate MRI using pelvic phased-array coil: utility for tumor detection prior to biopsy, Urol Oncol, 31, 1430, 10.1016/j.urolonc.2012.02.018

Delongchamps, 2013, Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies, J Urol, 189, 493, 10.1016/j.juro.2012.08.195

Fiard, 2013, Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion, Urology, 81, 1372, 10.1016/j.urology.2013.02.022

Kaufmann, 2015, Direct comparison of targeted MRI-guided biopsy with systematic transrectal ultrasound-guided biopsy in patients with previous negative prostate biopsies, Urol Int, 94, 319, 10.1159/000365397

Penzkofer, 2015, Transperineal in-bore 3-T MR imaging-guided prostate biopsy: a prospective clinical observational study, Radiology, 274, 170, 10.1148/radiol.14140221

Schimmoller, 2014, MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy, Eur Radiol, 24, 2582, 10.1007/s00330-014-3276-9

Mozer, 2015, First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer, BJU Int, 115, 50, 10.1111/bju.12690

Salami, 2014, Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer, Cancer, 120, 2876, 10.1002/cncr.28790

Salami, 2015, In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?, BJU Int, 115, 562, 10.1111/bju.12938

Shoji, 2015, Manually controlled targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: an early experience, Int J Urol, 22, 173, 10.1111/iju.12643

Ploussard, 2014, Impact of the type of ultrasound probe on prostate cancer detection rate and characterization in patients undergoing MRI-targeted prostate biopsies using cognitive fusion, World J Urol, 32, 977, 10.1007/s00345-013-1186-0

Kuru, 2014, Evolution of repeat prostate biopsy strategies incorporating transperineal and MRI-TRUS fusion techniques, World J Urol, 32, 945, 10.1007/s00345-014-1334-1

Iwamoto, 2014, The efficacy of target biopsy of suspected cancer lesions detected by magnetic resonance imaging and/or transrectal ultrasonography during initial prostate biopsies: comparison of outcomes between two physicians, Yonago Acta Med, 57, 53

Jambor, 2015, Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy, J Magn Reson Imaging, 41, 1394, 10.1002/jmri.24682

Boesen, 2015, Early experience with multiparametric magnetic resonance imaging-targeted biopsies under visual transrectal ultrasound guidance in patients suspicious for prostate cancer undergoing repeated biopsy, Scand J Urol, 49, 25, 10.3109/21681805.2014.925497

Habchi, 2014, Value of prostate multiparametric magnetic resonance imaging for predicting biopsy results in first or repeat biopsy, Clin Radiol, 69, e120, 10.1016/j.crad.2013.10.018

Sonn, 2014, Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen, Eur Urol, 65, 809, 10.1016/j.eururo.2013.03.025

Pepe, 2015, Can 3-Tesla pelvic phased-array multiparametric MRI avoid unnecessary repeat prostate biopsy in patients with PSA<10ng/mL?, Clin Genitourin Cancer, 13, e27, 10.1016/j.clgc.2014.06.013